Latest News and Press Releases

Chicago, May 15, 2024 (GLOBE NEWSWIRE) -- Oligonucleotide Synthesis market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at...

Wilmington, Delaware, United States, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global drug discovery informatics market is estimated to flourish at a CAGR of 10.9%...

Wilmington, Delaware, United States, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global AI in drug discovery market is projected to flourish at a CAGR of 36.1% from 2023...

New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The global oligonucleotide API market size is projected to expand at ~ 10% CAGR between 2023 and 2035. The market is expected to garner a revenue of USD...

Chicago, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Markets N Research has recently released expansive research on Global Clinical Trials Matching Software Market with 100+ market data Tables, Pie Chart, and...

Portland, OR, July 04, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Computer Aided Drug Discovery Market generated $2.9 billion in 2021, and is...

Redding,  California, Sept. 15, 2021 (GLOBE NEWSWIRE) -- According to a new market research report, “Precision Medicine Software Market by Deployment Mode (On-premise, Cloud-based), Application...

RUTHERFORD, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts,...

RUTHERFORD, N.J., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...

Third Quarter Revenue Grew 34% Over the Prior Year’s Quarter and 25% Year to Date Acquired BioPharma Business in Partnership with Ampersand Diagnostic Test Volume Grew 16% for the Quarter and...